CONMED CorpCNMD

Market cap

$1.3B

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenues	725	767	763	740	719	764	796	860	955	862	1,011	1,045	1,245	1,307
Cost of sales	350	361	350	336	337	355	365	391	430	402	443	474	568	574
Gross profit	375	406	412	404	382	408	431	469	525	460	568	571	676	733
Selling and administrative expense	277	302	311	294	303	338	352	356	400	374	415	454	503	478
Research and development expense	29	28	26	28	27	32	32	42	45	40	44	47	53	54
Operating expenses	367	341	356	351	331	371	384	398	446	414	458	501	556	533
Income from operations	8	65	57	53	51	38	47	71	79	46	110	70	121	200
Interest expense	7	6	6	6	6	15	18	21	43	44	35	29	40	37
Other expense	-	-	-	-	-	3	-	-	5	0	1	112	-	-
Income (loss) before income taxes	-	-	-	-	-	-	-	-	-	-	73	-71	81	163
Provision for income taxes	-3	19	15	14	15	5	-27	10	3	-8	11	10	16	31
Net income (loss)	1	40	36	32	30	15	55	41	29	10	63	-81	64	132
Earnings Per Share, Basic	0.03	1.43	1.3	1.17	1.1	0.53	1.99	1.45	1.01	0.33	2.14	-2.68	2.1	4.29
Earnings Per Share, Diluted	0.03	1.41	1.28	1.16	1.09	0.52	1.97	1.41	0.97	0.32	1.94	-2.68	2.04	4.25
Cash flow hedging	-	-	-	-	-	-	-	-	-	-8	13	-2	-3	6
Pension liability	-	-	-18	19	-8	1	-1	1	-0	6	-9	-8	-7	-2
Foreign currency translation adjustments	-	-	-1	-15	-17	-5	14	-8	0	7	-7	-8	5	-15
Other comprehensive income (loss), before income tax	-	-	53	6	18	10	62	43	24	-8	15	-2	9	-7
Other Comprehensive Income (Loss), Tax	-	-	7	-4	2	-0	-3	2	-1	-4	5	2	1	2
Other comprehensive income (loss), net of income tax	-	-	-	-	-	-	-	-	-	-4	9	-4	8	-9
Comprehensive income (loss)	-	-	46	10	16	10	65	40	25	5	72	-84	72	124